Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 25 or more amino acid residues in defined sequence
Patent
1993-09-13
1994-09-13
Nucker, Christine M.
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
25 or more amino acid residues in defined sequence
530325, 4241881, 4242081, A61K 3702, A61K 3912, A61K 3700, C07K 500
Patent
active
053469895
ABSTRACT:
Peptides corresponding to regions of the human immunodeficiency virus protein gp-120 are provided for eliciting T-cell activation.
REFERENCES:
patent: 4943628 (1990-07-01), Rosen et al.
Alizon, et al., 1986 "Gemehc variability of the AIDS virus: . . . " Cell vol. 46: 63-74.
Ho, et al., 1988, "Second conserved domain of gpl20 is important . . . " Science 239: 1021-1023.
Manca, F., "The Naive Repertoire of Human T Helper Cells Specific for gp230, the Envelope Glycoprotein of HIV", J. Immunol, Mar. 15, 1991, pp. 1964-1971 (Abstract only).
M. Clerici, "Immunization with subunit human immunodeficiency virus vaccine generates stronger T helper cell immunity than natural infection", Eur J. Immunol, pp. 1345-1349, Jun. 1991.
McDougal, J. S. et al., "HIV Binding to the CD4 Molecule: Conformation Dependence and Binding Inhibition Studies", Human Retroviruses, Cancer, and AIDS, Symposium hel at Keystone, CO, Apr. 1987.
Kenealy, W. et al., "Antibodies from Human Immunodeficiency Virus-Infected Individuals Bind to a Short Amino Acid Sequence that Elicits Neutralizing Antibodies in Animals", Aids Research and Human Retroviruses, vol. 5, No. 2 1989.
Wahren, B., "HIV-1 Peptides Induce a Proliferative Response in Lymphocytes from Infected Persons", Journal of Acquired Immune Deficiency Syndromes, vol. 2, No. 5, pp. 448-456, 1989.
Modrow, S. et al., "Use of Synthetic Oligopeptides in Indentification and Characterization of Immunological Functions in the Amino Acid Sequence of the Envelope Protein of HIV-1", Journal of Acquired Immune Deficiency Syndromes, vol. 2, No. 1, 1989.
Krychnak, V. et al., "Color-Monitored Solid-Phase Multiple Peptide Synthesis Under Low-Pressure Continuous-Flow Conditions", Peptide Research, vol. 3 No. 4, 1990.
Neurath, A. et al., "B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-reside) synthetic peptides", Journal of General Virology, pp. 85-95, 1990.
Dadaglio, G. et al., "Epitope Recognition of Conserved HIV Envelope Sequences by Human Cytotoxic T Lymphocytes", Journal of Immunology vol. 147, 2302-2309, No. 7, Oct. 1, 1991.
Neurath, A. et al., "Peptides Mimicking Selected Disulfide Loops in HIV-1 gp120, Other Than V3, Do Not Elicit Virus-Neutralizing Antibodies", Aids Research and Human Retroviruses, vol. 7, No. 8, 1991.
Vahlne, A. et al., "Immunizations of Monkeys with Synthetic Peptides Disclose Conserved Areas on gp120 of Human Immunodeficiency Virus Type 1 Associated with Cross-Neutralizing Antibodies and T-cell Recognition", Proc. Natl. Acad. Sci, USA, vol. 88, pp. 10744-10748, Dec. 1991.
Barre-Sinoussi et al., "Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)", Science, 220:868 (1983).
Gallo et al., "Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS", Science, 224:500 (1984).
Allan et al., "Major Glycoprotein Antigens That Induce Antibodies in AIDS Patients Are Encoded by HTLV-III", Science, 228:1091-1094 (1985).
Barin et al., "Virus Envelope Protein of HTLV-III Represents Major Target Antigen for Antibodies in AIDS Patients", Science, 228:1094-1096 (1985).
Cabradilla et al., "Serodiagnosis of Antibodies to the Human AIDS Retrovirus With a Bacterially Synthesized env Polypeptide", Biotechnology, 4:128-133 (1986).
Chang et al., "Detection of Antibodies to Human T-Cell Lymphotropic Virus-III (HTLV-III) With An Immunoassay Employing a Recombinant Escherichia Coli-Derived Viral Antigenic Peptide", Biotechnology, 3:905-909 (1985).
Kennedy et al., "Antiserum to a Synthetic Peptide Recognizes the HTLV-III Envelope Glycoprotein", Science, 231:1556-1559 (1986).
Ranki et al., "Neutralizing antibodies in HIV (HTLV-III) Infection: Correlation With Clinical Outcome and Antibody Response Against Different Viral Proteins", Clin. Exp. Immunol., 69:231 (1987).
Marx, "New Hope on the AIDS Vaccine Front", Science, 224:1254 (1989).
Reinherz et al., "The Characterization and Function of Human Immunoregulatory T Lymphocyte Subsets", Immunol. Today, 2:69 (1981).
Burns et al., "Thymus Dependence of Viral Antigens", Nature, 256:654 (1975).
Askonas et al., "Cytotoxic T-Memory Cells in Virus Infection and the Specificity of Helper T Cells", Immunology, 45:79 (1982).
Berkower et al., "A Possible Immunodominant Epitope Recognized By Murine T Lymphocytes Immune to Different Myoglobins", Proc. Natl. Acad. Sci. U.S.A., 79:4723-4727 (1982).
DeLisi et al., "T-Cell Antigenic Sites Tend to be Amphipathic Structures", Proc. Natl. Acad. Sci. U.S.A., 82:7048-7052 (1985).
Margalit et al., "Prediction of Immunodominant Helper T Cell Antigenic Sites From The Primary Sequence", J. Immunol., 138:2213-2229 (1987).
Milich et al., "Nonoverlapping T and B Cell Determinants on an Hepatitis B Surface Antigen Pre-S(2) Region Synthetic Peptide", J. Exp. Med., 164:532-547 (1986).
Krzych et al., "Induction of Helper and Suppressor T Cells by Nonoverlapping Determinants on the Large Protein Antigen, .beta.-Galactosidase", FASEB. J., 2:141-145 (1988).
Terpstra et al., "Longitudinal Study of Leukocyte Functions In Homosexual Men Seroconverted for HIV:Rapid and Persistent Loss of B Cell Function After HIV Infection", Eur. J. Immunol., 19:667-673 (1989).
Fahey et al., "Quantitative Changes in T Helper Or T Suppressor/Cytotoxic Lymphocyte Subsets That Distinguish Acquired Immune Deficiency Syndrome from Other Immune Subset Disorders", JAMA, 76:95-100 (1984).
Shearer et al., "Functional T Lymphocyte Immune Deficiency Syndrome in a Population of Homosexual Men Who do Not Exhibit Symptoms of Acquired Immune Deficiency Syndrome", J. Clin. Invest., 74:496-506 (1984).
Giorgi et al., "Early Effects of HIV on CD4 Lymphocytes In Vivo", J. Immunol., 138:3725-3730 (1987).
van Noesel et al., "Functional and Phenotypic Evidence for a Selective Loss of Memory T Cells in Asymptomatic Human Immuno-deficiency Virus--infected Men", J. Clin. Invest., 86:293-299.
Milich et al., "A Single 10-Residue Pre-S(1) Peptide Can Prime T Cell Help For Antibody Production To Multiple Epitopes Within The Pre-S(1), Pre-S(2) And S Regions of HBsAg.sup.1 ", J. Immunol., 138:4457 (1987).
Kennedy et al., "Antiserum to a Synthetic Peptide Recognizes the HTLV-III Envelope Glycoprotein", Science, 231:1556-1559 (1986).
Bolognesi, "HIV Antibodies and Vaccine Design", AIDS, 3:S111-S118 (1989).
Javaherian et al., "Broadly Neutralizing Antibodies Elicited by the Hypervariable Neutralizing Determinant of HIV-1", Science, 250:1590-1593 (1990).
Rusche et al., "Antibodies that Inhibit Fusion of Human Immunodeficiency Virus-Infected Cells Bind a 24-Amino Acid Sequence of the Viral Envelope, gp120", Proc. Natl. Acad. Sci. USA, 85:3198-3202 (1988).
Lerner et al., in, The Biology of Immunological Disease: A Hospital Practice Book, (Dixon and Fisher, eds.) pp. 331-338 (1983).
Lerner, "Antibodies of Predetermined Specificity in Biology and Medicine", Adv. Immunol., 36:1-44 (1984).
Van Regenmortel, "Synthetic Peptides As Viral Vaccines", Ann. Inst. Pasteur Virol., 137E:497-528 (1986).
Erickson and Merrifield in The Proteins, 3rd Edit., vol. 2, Academic Press, New York, Chapter 3 (1976).
Cianciolo et al., "Macrophage Accumulation in Mice is Inhibited by Low Molecular Weight Products From Murine Leukemia Viruses", J. Immunol., 124:2900-2905 (1980).
Cianciolo et al., "Inhibition of Lymphocyte Proliferation by a Synthetic Peptide Homologous to Retroviral Envelope Proteins", Nature, 230:453-455 (1985).
Steward et al., "Synthetic Peptides: A Next Generation of Vaccines?", Immunol. Today, 8:51-58 (1987).
Berman et al., "Protection of Chimpanzees From Infection by HIV-1 After Vaccination with Recombinant Glycoprotein gp120 but not gp160", Nature, 345:622-625 (1990).
Ho et al., "Second Conserved Domain of gp120 Is Important for HIV Infectivity and Antibody Neutralization", Science, 239:1021-1023 (1988).
Muesing et al., "Nucleic Acid Structure and Expression of the Human AIDS/Lymphadenopathy Retrovirus", Nature, 313:450-458 (1985).
Mierke et al., "Morphiceptin Analogs Containing 2-Aminocyclopentane Carboxylic
Czerkinsky Cecil
Holmgren Jan
Horal Peter
Jeansson Stig
Rymo Lars
Nucker Christine M.
Smith Lynette R. F.
Syntello Vaccine Development KB
LandOfFree
Peptides for use in induction of T cell activation against HIV-1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides for use in induction of T cell activation against HIV-1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides for use in induction of T cell activation against HIV-1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1121275